Cryptococcosis: Population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons

Journal of Infectious Diseases

Volumn 179, Issue 2, 1999, Pages 449-454

  Hajjeh, Rana A ^a   Conn, Laura A ^b   Stephens, David S ^b   Baughman, Wendy ^b   Hamill, Richard ^b   Graviss, Edward ^b   Pappas, Peter G ^b   Thomas, Carolynn ^b   Reingold, Arthur ^b   Rothrock, Gretchen ^b   Hutwagner, Lori C ^b   Schuchat, Anne ^b   Brandt, Mary E ^b   Pinner, Robert W ^b   Farley, Monica ^b   Bardsley, Molly ^b   Siegel, Betsy ^b   Jackson, Georgia ^b   Lao, Chris ^b   Otte, Jodie ^b   Harvey, Christopher ^b   Rimland, David ^b   Gillespie, Roger ^b   Pattni, Bharat ^b   Daily, Pam ^b   Shihata, Nivin ^b   Durry, Elias ^b   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CRYPTOCOCCOSIS; DEMOGRAPHY; FEMALE; GEORGIA; HUMANS; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); RISK FACTORS; SAN FRANCISCO; TEXAS;

EID: 0033021986     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314606     Document Type: Article

References (19)

1. Selik RM, Karon JM, Ward JW. Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993. J Infect Dis 1997;176:632-6.
2. Hajjeh RA, Brandt ME, Pinner RW. The emergence of cryptococcal disease: epidemiologic perspectives 100 years after its discovery. Epidemiol Rev 1996;17:303-20.
3. Muchmore HG, Rhoades ER, Nix GE, Felton FG, Carpenter RE. Occurrence of Cryptococcus neoformans in the environment of three geographically associated cases of cryptococcal meningitis. N Engl J Med 1963;268:1112-4.
4. Procknow JJ, Benfield JR, Rippon JW. Cryptococcal hepatitis presenting as a surgical emergency. JAMA 1965;191:269-74.
5. White PD, Kaufman L, Weeks RJ. Cryptococcal meningitis: a case report and epidemiological study. J Med Assoc Ga 1982;71:539-42.
6. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 1997;337:970-6.
7. Brandt ME, Hutwagner LC, Klug LA, et al. Molecular subtype distribution of C. neoformans in four areas of the U.S. J Clin Microbiol 1996;34:912-7.
8. Powderly WG, Finkelstein DM, Feinberg J, et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced HIV infection. N Engl J Med 1995;332:700-5.
9. Quagliarello VJ, Viscoli C, Horwitz RI. Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients. Lancet 1995;345:548-52.
10. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984;120:123-30.
11. Castro KG, Selik RM, Jaffe HW. Frequency of opportunistic diseases in AIDS patients, by race, ethnicity, and HIV transmission categories-United States. In: Program and abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy (Los Angeles). Washington, DC: American Society for Microbiology, 1988.
12. Pinner RW, Hutwagner L, Collin SF. Use of hospital discharge data to describe recent changes in the epidemiology of cryptococcal disease. In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 1991.
13. Fischer M, Hedberg K, Cardosi P, et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J 1997;16:979-83.
14. Dromer F, Ronin O, Dupont B. Isolation of Cryptococcus neoformans var. gattii from an Asian patient in France: evidence for dormant infection in healthy subjects. J Med Vet Mycol 1992;30:395-7.
15. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine 1990;69:361-74.
16. Fessel WJ. Cryptococcal meningitis after unusual exposures to birds. N Engl J Med 1993;328:1354-5.
17. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV. Ann Intern Med 1997;127:922-46.
18. Reeves WG, Wilson RM. Infection, immunity, and diabetes. In: Alberti KGGM, ed. International textbook of diabetes mellitus. New York: John Wiley & Sons, 1992.
19. Centers for Disease Control and Prevention. Update: trends in AIDS incidence. MMWR Morb Mortal Wkly Rep 1997;46:165-73.